Perhaps the most useful contribution of this paper is that it readily demonstrates why the approach being used by Stan Glantz to assess the effectiveness of e-cigarettes for smoking cessation is inappropriate and leads to erroneous conclusions.

A new published today in the journal Tobacco Control demonstrates why the FDA's proposed regulatory approach for electronic cigarettes makes no sense. In fact, the new research shows why the FDA's approach would be a complete bureaucratic nightmare, while not actually protecting the public's health.

Another recent study published late May in the Addiction Journal showed that the e-vapor produced in electronic cigarettes “can contain some of the toxinspresent in tobacco smoke, but at levels which are much lower.” This study conducted by 5 researchers, 2 of which were linked to a Federal Drug Administration tobacco panel, used approximately 81 different studies during its overall review. In conjunction, a scientific review on e-cigs from theconcluded with the comparison of conventional cigarettes, claiming that they are less likely to be as harmful. Peter Hajek of Londons Queen Mary University states “the evidence we currently have is clear: e-cigarettes should be allowed to compete against conventional cigarettes in the marketplace. Health care professionals may advise smokers who are unwilling to cease nicotine use to switch to e-cigarettes. Smokers who have not managed to stop with current treatments may also benefit from switching to e-cigarettes.”

LAST：Newest RBA Atomizer iGo -W6 Style iGo - W4 Atomizer Cloutank M3 on sale in USA market |NEXT：Hotcig high quality origen v2 clone origen v2 atomizer origen v2 dripper clone atomizer